Pharmacological studies on droxicainide, a new antiarrhythmic agent

Area of Science:

• Pharmacology
• Toxicology
• Anesthesiology

Background:

• Lidocaine is a widely used local anesthetic and antiarrhythmic drug.
• There is a continuous need for safer and equally effective anesthetic and antiarrhythmic agents.

Purpose of the Study:

• To compare the antiarrhythmic, local anesthetic, and toxic effects of droxicainide (AL-S-1249) with lidocaine in animal models.
• To evaluate the potential of droxicainide as a safer alternative to lidocaine.

Main Methods:

• Intravenous administration in guinea pigs to assess antiarrhythmic activity against ouabain-induced arrhythmias.
• Intradermal and corneal application in guinea pigs and rabbits, respectively, for local anesthetic efficacy.
• Sciatic nerve injection in rats to evaluate motor and sensory blockade.
• Intravenous administration to mice and rats to determine LD50 values for systemic toxicity assessment.

Main Results:

• Droxicainide and lidocaine showed equipotent and similar duration of antiarrhythmic action.
• Both agents produced equivalent sensory anesthesia and nerve blockade.
• Droxicainide exhibited reduced local tissue irritation compared to lidocaine.
• Droxicainide demonstrated higher LD50 values, indicating lower systemic toxicity than lidocaine.

Conclusions:

• Droxicainide possesses antiarrhythmic and local anesthetic properties comparable to lidocaine.
• Droxicainide presents a potentially improved safety profile with lower local and systemic toxicity.
• Further research into the antiarrhythmic and local anesthetic applications of droxicainide is recommended.